Abingdon, United Kingdom · Founded 2006 · Privately Held (backing)
Operator of a clinical-stage oncology company intended to develop cancer gene therapies. Akamis Bio is based in Abingdon, United Kingdom and was founded in 2006. Its last reported valuation was $145 million in Jan 2023. It has raised $185 million.
Last reported valuation
$145.3M
Oct 2026
Priced at
—
Total raised
$184.6M
Last round
—
Cap table — not yet on record
Akamis Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Akamis Bio with a free account
·The complete investor list: 25 names
·Watch Akamis Bio: the Monday email on marks, rounds and moves
